Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells

Nucleic Acids Research

Volumn 40, Issue 14, 2012, Pages 6683-6692

  Sachdeva, Mohit ^a   Liu, Qian ^a   Cao, Julia ^a   Lu, Zhaohui ^b   Mo, Yin Yuan ^a,c  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; MICRORNA 145; PROTEIN KINASE B; PROTEIN P53;

ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER CELL; CONTROLLED STUDY; DIMERIZATION; DOWN REGULATION; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; UPREGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STILBENES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84864307724     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks324     Document Type: Article

References (44)

1. Calin, G.A. and Croce, C.M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866. (Pubitemid 44629897)
2. Johnson, S.M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K.L., Brown, D. and Slack, F.J. (2005) RAS is regulated by the let-7 microRNA family. Cell, 120, 635-647. (Pubitemid 40343076)
3. Cimmino, A., Calin, G.A., Fabbri, M., Iorio, M.V., Ferracin, M., Shimizu, M., Wojcik, S.E., Aqeilan, R.I., Zupo, S., Dono, M. et al. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl Acad. Sci. USA, 102, 13944-13949. (Pubitemid 41377683)
4. Zhu, S., Si, M.L., Wu, H. and Mo, Y.Y. (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem., 282, 14328-14336. (Pubitemid 47100416)
5. Si, M.L., Zhu, S., Wu, H., Lu, Z., Wu, F. and Mo, Y.Y. (2007) miR-21-mediated tumor growth. Oncogene, 26, 2799-2803. (Pubitemid 46663837)
6. Chan, J.A., Krichevsky, A.M. and Kosik, K.S. (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res., 65, 6029-6033. (Pubitemid 40994386)
7. Michael, M.Z., O' Connor, S.M., van Holst Pellekaan, N.G., Young, G.P. and James, R.J. (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res., 1, 882-891. (Pubitemid 37288707)
8. Sempere, L.F., Christensen, M., Silahtaroglu, A., Bak, M., Heath, C.V., Schwartz, G., Wells, W., Kauppinen, S. and Cole, C.N. (2007) Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res., 67, 11612-11620.
9. Iorio, M.V., Ferracin, M., Liu, C.G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M. et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res., 65, 7065-7070. (Pubitemid 41161233)
10. Schepeler, T., Reinert, J.T., Ostenfeld, M.S., Christensen, L.L., Silahtaroglu, A.N., Dyrskjot, L., Wiuf, C., Sorensen, F.J., Kruhoffer, M., Laurberg, S. et al. (2008) Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res., 68, 6416-6424.
11. Sachdeva, M., Zhu, S., Wu, F., Wu, H., Walia, V., Kumar, S., Elble, R., Watabe, K. and Mo, Y.Y. (2009) p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl Acad. Sci. USA, 106, 3207-3212.
12. Shi, B., Sepp-Lorenzino, L., Prisco, M., Linsley, P., deAngelis, T. and Baserga, R. (2007) Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J. Biol. Chem., 282, 32582-32590. (Pubitemid 350159311)
13. Sachdeva, M. and Mo, Y.Y. (2010) MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res., 70, 378-387.
14. Yang, B., Guo, H., Zhang, Y., Chen, L., Ying, D. and Dong, S. (2011) MicroRNA-145 regulates chondrogenic differentiation of mesenchymal stem cells by targeting Sox9. PLoS One, 6, e21679.
15. Xu, Q., Liu, L.Z., Qian, X., Chen, Q., Jiang, Y., Li, D., Lai, L. and Jiang, B.H. (2011) MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res., 40, 761-774.
16. Yu, T., Wang, X.Y., Gong, R.G., Li, A., Yang, S., Cao, Y.T., Wen, Y.M., Wang, C.M. and Yi, X.Z. (2009) The expression profile of microRNAs in a model of 7, 12-dimethyl-benz[a]anthranceinduced oral carcinogenesis in Syrian hamster. J. Exp. Clin. Cancer Res., 28, 64.
17. Cordes, K.R., Sheehy, N.T., White, M.P., Berry, E.C., Morton, S.U., Muth, A.N., Lee, T.H., Miano, J.M., Ivey, K.N. and Srivastava, D. (2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature, 460, 705-710.
18. Gan, B., Lim, C., Chu, G., Hua, S., Ding, Z., Collins, M., Hu, J., Jiang, S., Fletcher-Sananikone, E., Zhuang, L. et al. (2010) FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis. Cancer Cell, 18, 472-484.
19. Kent, O.A., Chivukula, R.R., Mullendore, M., Wentzel, E.A., Feldmann, G., Lee, K.H., Liu, S., Leach, S.D., Maitra, A. and Mendell, J.T. (2010) Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes Dev., 24, 2754-2759.
20. She, Q.B., Bode, A.M., Ma, W.Y., Chen, N.Y. and Dong, Z. (2001) Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res., 61, 1604-1610. (Pubitemid 34292594)
21. Descombes, P. and Schibler, U. (1991) A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell, 67, 569-579. (Pubitemid 121001471)
22. Chen, C., Ridzon, D.A., Broomer, A.J., Zhou, Z., Lee, D.H., Nguyen, J.T., Barbisin, M., Xu, N.L., Mahuvakar, V.R., Andersen, M.R. et al. (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res., 33, e179.
23. Gupta, A. and Mo, Y.Y. (2011) Detection of microRNAs in cultured cells and paraffin-embedded tissue specimens by in situ hybridization. Methods Mol. Biol., 676, 73-83.
24. Kandel, E.S., Skeen, J., Majewski, N., Di Cristofano, A., Pandolfi, P.P., Feliciano, C.S., Gartel, A. and Hay, N. (2002) Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Mol. Cell Biol., 22, 7831-7841. (Pubitemid 35217294)
25. Aggarwal, B.B., Bhardwaj, A., Aggarwal, R.S., Seeram, N.P., Shishodia, S. and Takada, Y. (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res., 24, 2783-2840. (Pubitemid 39409568)
26. Jang, M., Cai, L., Udeani, G.O., Slowing, K.V., Thomas, C.F., Beecher, C.W., Fong, H.H., Farnsworth, N.R., Kinghorn, A.D., Mehta, R.G. et al. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220. (Pubitemid 127696281)
27. Bartek, J., Iggo, R., Gannon, J. and Lane, D.P. (1990) Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene, 5, 893-899.
28. Tang, H.Y., Shih, A., Cao, H.J., Davis, F.B., Davis, P.J. and Lin, H.Y. (2006) Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells. Mol. Cancer Ther., 5, 2034-2042. (Pubitemid 44336575)
29. Xiong, W., Hsieh, C.C., Kurtz, A.J., Rabek, J.P. and Papaconstantinou, J. (2001) Regulation of CCAAT/enhancerbinding protein-beta isoform synthesis by alternative translational initiation at multiple AUG start sites. Nucleic Acids Res., 29, 3087-3098. (Pubitemid 32685235)
30. Eaton, E.M., Hanlon, M., Bundy, L. and Sealy, L. (2001) Characterization of C/EBPbeta isoforms in normal versus neoplastic mammary epithelial cells. J. Cell Physiol., 189, 91-105.
31. Ewing, S.J., Zhu, S., Zhu, F., House, J.S. and Smart, R.C. (2008) C/EBPbeta represses p53 to promote cell survival downstream of DNA damage independent of oncogenic Ras and p19(Arf). Cell Death Differ., 15, 1734-1744.
32. Schneider-Merck, T., Pohnke, Y., Kempf, R., Christian, M., Brosens, J.J. and Gellersen, B. (2006) Physical interaction and mutual transrepression between CCAAT/enhancer-binding protein beta and the p53 tumor suppressor. J. Biol. Chem., 281, 269-278. (Pubitemid 43671186)
33. Aziz, M.H., Nihal, M., Fu, V.X., Jarrard, D.F. and Ahmad, N. (2006) Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 30-kinase/Akt pathway and Bcl-2 family proteins. Mol. Cancer Ther., 5, 1335-1341. (Pubitemid 43881327)
34. Xu, N., Papagiannakopoulos, T., Pan, G., Thomson, J.A. and Kosik, K.S. (2009) MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell, 137, 647-658.
35. O'Hara, S.P., Splinter, P.L., Gajdos, G.B., Trussoni, C.E., Fernandez-Zapico, M.E., Chen, X.M. and LaRusso, N.F. (2010) NFkappaB p50-CCAAT/enhancer-binding protein beta (C/EBPbeta)-mediated transcriptional repression of microRNA let-7i following microbial infection. J. Biol. Chem., 285, 216-225.
36. Ewing, S.J., Zhu, S., Zhu, F., House, J.S. and Smart, R.C. (2008) C/EBPbeta represses p53 to promote cell survival downstream of DNA damage independent of oncogenic Ras and p19(Arf). Cell Death Differ., 15, 1734-1744.
37. Wang, W., Li, Q., Bagchi, I.C. and Bagchi, M.K. (2010) The CCAAT/enhancer binding protein beta is a critical regulator of steroid-induced mitotic expansion of uterine stromal cells during decidualization. Endocrinology, 151, 3929-3940.
38. Di-Poi, N., Desvergne, B., Michalik, L. and Wahli, W. (2005) Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins. J. Biol. Chem., 280, 38700-38710. (Pubitemid 43853773)
39. Burkart, A.D., Mukherjee, A., Sterneck, E., Johnson, P.F. and Mayo, K.E. (2005) Repression of the inhibin alpha-subunit gene by the transcription factor CCAAT/enhancer-binding protein-beta. Endocrinology, 146, 1909-1921. (Pubitemid 40396900)
40. Zahnow, C.A., Younes, P., Laucirica, R. and Rosen, J.M. (1997) Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer. J. Natl Cancer Inst., 89, 1887-1891. (Pubitemid 28009825)
41. Bundy, L.M. and Sealy, L. (2003) CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture. Oncogene, 22, 869-883. (Pubitemid 36255823)
42. Kim, M.H. and Fields, J. (2008) Translationally regulated C/EBP beta isoform expression upregulates metastatic genes in hormone-independent prostate cancer cells. Prostate, 68, 1362-1371.
43. Wang, W.L., Lee, Y.C., Yang, W.M., Chang, W.C. and Wang, J.M. (2008) Sumoylation of LAP1 is involved in the HDAC4-mediated repression of COX-2 transcription. Nucleic Acids Res., 36, 6066-6079.
44. Howitz, K.T., Bitterman, K.J., Cohen, H.Y., Lamming, D.W., Lavu, S., Wood, J.G., Zipkin, R.E., Chung, P., Kisielewski, A., Zhang, L.L. et al. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 425, 191-196. (Pubitemid 37150899)